Real-World Treatment and Outcomes for Patients With Deficient Mismatch Repair Metastatic Colorectal Cancer Following Pembrolizumab Availability in Australia
Real-World Treatment and Outcomes for Patients With Deficient Mismatch Repair Metastatic Colorectal Cancer Following Pembrolizumab Availability in Australia. // Clinical Colorectal Cancer. – URL: https://www.sciencedirect.com/science/article/pii/S153300282600071X?dgcid=rss_sd_all
Real-World Treatment and Outcomes for Patients With Deficient Mismatch Repair Metastatic Colorectal Cancer Following Pembrolizumab Availability in Australia. Clinical Colorectal Cancer. https://www.sciencedirect.com/science/article/pii/S153300282600071X?dgcid=rss_sd_all
“Real-World Treatment and Outcomes for Patients With Deficient Mismatch Repair Metastatic Colorectal Cancer Following Pembrolizumab Availability in Australia.” Clinical Colorectal Cancer.
@article{article40529,
title = {Real-World Treatment and Outcomes for Patients With Deficient Mismatch Repair Metastatic Colorectal Cancer Following Pembrolizumab Availability in Australia},
journal = {Clinical Colorectal Cancer},
url = {https://www.sciencedirect.com/science/article/pii/S153300282600071X?dgcid=rss_sd_all}
}